V-Bio Ventures

V-Bio Ventures is a prominent independent venture capital firm based in Gent, Belgium, dedicated to investing in innovative life sciences companies. Established in 2015, the firm leverages its strong ties with the Flanders Institute for Biotechnology (VIB) to identify and nurture groundbreaking scientific discoveries, primarily focusing on therapeutics, diagnostics, and medical devices. Their investment philosophy centers on transforming cutting-edge research into viable commercial entities that address significant unmet medical needs.

The firm has successfully raised two substantial funds, demonstrating robust investor confidence and an expanding capacity for investment. Their inaugural fund, V-Bio Ventures Fund I, closed at €75 million in 2015, providing the initial capital for their early investments. Building on this success, they closed their second fund, V-Bio Ventures Fund II, at a substantial €120 million in 2021, significantly increasing their firepower for new opportunities. V-Bio Ventures typically acts as a lead or co-lead investor, frequently participating in syndicates with other specialized life sciences VCs to provide comprehensive funding and support.

V-Bio Ventures primarily targets seed and Series A rounds, providing crucial capital for preclinical and early clinical development stages. Their initial investment checks generally range from $1 million to $5 million, with a strategic commitment to support portfolio companies through subsequent funding rounds. Beyond capital, V-Bio Ventures offers invaluable strategic guidance, operational support, and access to their extensive network within the biotech and pharmaceutical industries, aiming to accelerate the growth and success of their portfolio companies from scientific concept to market realization.